The regulation of mobile medical applications

The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications...

Full description

Saved in:
Bibliographic Details
Published inLab on a chip Vol. 14; no. 5; pp. 833 - 84
Main Authors Yetisen, Ali Kemal, Martinez-Hurtado, J. L, da Cruz Vasconcellos, Fernando, Simsekler, M. C. Emre, Akram, Muhammad Safwan, Lowe, Christopher R
Format Journal Article
LanguageEnglish
Published England 07.03.2014
Subjects
Online AccessGet full text
ISSN1473-0197
1473-0189
1473-0189
DOI10.1039/c3lc51235e

Cover

Abstract The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications and protect consumers by minimising the risks associated with their unintended use. This guidance distinguishes between the subset of mobile medical apps which may be subject to regulation and those that are not. The marketing claims of the application determine the intent. Areas of concern include compliance with regular updates of the operating systems and of the mobile medical apps themselves. In this article, we explain the essence of this FDA guidance by providing examples and evaluating the impact on academia, industry and other key stakeholders, such as patients and clinicians. Our assessment indicates that awareness and incorporation of the guidelines into product development can hasten the commercialisation and market entry process. Furthermore, potential obstacles have been discussed and directions for future development suggested. The article explains the regulation of mobile medical applications and evaluates their impact on academia, industry, patients and clinicians.
AbstractList The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications and protect consumers by minimising the risks associated with their unintended use. This guidance distinguishes between the subset of mobile medical apps which may be subject to regulation and those that are not. The marketing claims of the application determine the intent. Areas of concern include compliance with regular updates of the operating systems and of the mobile medical apps themselves. In this article, we explain the essence of this FDA guidance by providing examples and evaluating the impact on academia, industry and other key stakeholders, such as patients and clinicians. Our assessment indicates that awareness and incorporation of the guidelines into product development can hasten the commercialisation and market entry process. Furthermore, potential obstacles have been discussed and directions for future development suggested.The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications and protect consumers by minimising the risks associated with their unintended use. This guidance distinguishes between the subset of mobile medical apps which may be subject to regulation and those that are not. The marketing claims of the application determine the intent. Areas of concern include compliance with regular updates of the operating systems and of the mobile medical apps themselves. In this article, we explain the essence of this FDA guidance by providing examples and evaluating the impact on academia, industry and other key stakeholders, such as patients and clinicians. Our assessment indicates that awareness and incorporation of the guidelines into product development can hasten the commercialisation and market entry process. Furthermore, potential obstacles have been discussed and directions for future development suggested.
The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications and protect consumers by minimising the risks associated with their unintended use. This guidance distinguishes between the subset of mobile medical apps which may be subject to regulation and those that are not. The marketing claims of the application determine the intent. Areas of concern include compliance with regular updates of the operating systems and of the mobile medical apps themselves. In this article, we explain the essence of this FDA guidance by providing examples and evaluating the impact on academia, industry and other key stakeholders, such as patients and clinicians. Our assessment indicates that awareness and incorporation of the guidelines into product development can hasten the commercialisation and market entry process. Furthermore, potential obstacles have been discussed and directions for future development suggested. The article explains the regulation of mobile medical applications and evaluates their impact on academia, industry, patients and clinicians.
The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the turnaround time and reducing costs. In September 2013, the U.S. Food and Drug Administration (FDA) issued guidance to regulate these applications and protect consumers by minimising the risks associated with their unintended use. This guidance distinguishes between the subset of mobile medical apps which may be subject to regulation and those that are not. The marketing claims of the application determine the intent. Areas of concern include compliance with regular updates of the operating systems and of the mobile medical apps themselves. In this article, we explain the essence of this FDA guidance by providing examples and evaluating the impact on academia, industry and other key stakeholders, such as patients and clinicians. Our assessment indicates that awareness and incorporation of the guidelines into product development can hasten the commercialisation and market entry process. Furthermore, potential obstacles have been discussed and directions for future development suggested.
Author da Cruz Vasconcellos, Fernando
Lowe, Christopher R
Simsekler, M. C. Emre
Yetisen, Ali Kemal
Akram, Muhammad Safwan
Martinez-Hurtado, J. L
AuthorAffiliation Department of Engineering
University of Cambridge
Department of Chemical Engineering and Biotechnology
AuthorAffiliation_xml – name: Department of Chemical Engineering and Biotechnology
– name: Department of Engineering
– name: University of Cambridge
Author_xml – sequence: 1
  givenname: Ali Kemal
  surname: Yetisen
  fullname: Yetisen, Ali Kemal
– sequence: 2
  givenname: J. L
  surname: Martinez-Hurtado
  fullname: Martinez-Hurtado, J. L
– sequence: 3
  givenname: Fernando
  surname: da Cruz Vasconcellos
  fullname: da Cruz Vasconcellos, Fernando
– sequence: 4
  givenname: M. C. Emre
  surname: Simsekler
  fullname: Simsekler, M. C. Emre
– sequence: 5
  givenname: Muhammad Safwan
  surname: Akram
  fullname: Akram, Muhammad Safwan
– sequence: 6
  givenname: Christopher R
  surname: Lowe
  fullname: Lowe, Christopher R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24425070$$D View this record in MEDLINE/PubMed
BookMark eNqFkEtLxDAURoOMOA_duFfqToRq0iRtspTBFwy4GdchTROtpE1N2oX_3ozzEEV0dS9857twzxSMWtdqAI4RvEQQ8yuFraIow1TvgQkiBU4hYny023kxBtMQXiFElOTsAIwzQjIKCzgB6fJFJ14_D1b2tWsTZ5LGlbXVSaOrWkmbyK6zcVml4RDsG2mDPtrMGXi6vVnO79PF493D_HqRKgJpn-IKMcZQIQk3jBFllMo4ZJU0GmeszGUpC4IwNpXBRkKdcyUxZbSMjGYkxzNwvr7befc26NCLpg5KWytb7YYgUEExhRQV8H-UcI5wFo1E9HSDDmX8TnS-bqR_F1sbEYBrQHkXgtdGqLr__Lz3srYCQbESLr6Ex8rFj8r26q_wyRr2Qe24b_nZX7nooq8PQVyUUw
CitedBy_id crossref_primary_10_3390_data7120177
crossref_primary_10_1186_s12895_018_0071_3
crossref_primary_10_2196_15940
crossref_primary_10_1080_13698575_2015_1127333
crossref_primary_10_1007_s11916_018_0718_0
crossref_primary_10_1177_1357633X211045186
crossref_primary_10_1136_bmjhci_2019_000017
crossref_primary_10_1002_adma_201502382
crossref_primary_10_1080_23311908_2020_1843883
crossref_primary_10_1371_journal_pone_0165263
crossref_primary_10_2196_20730
crossref_primary_10_1039_C9NR09152A
crossref_primary_10_1039_c4lc00399c
crossref_primary_10_2196_mhealth_5361
crossref_primary_10_1016_j_ijnss_2014_08_002
crossref_primary_10_2196_16741
crossref_primary_10_3390_soc4040606
crossref_primary_10_2196_jmir_3133
crossref_primary_10_3389_fneur_2023_1258635
crossref_primary_10_1039_C7AN01987D
crossref_primary_10_1109_TBCAS_2023_3348844
crossref_primary_10_1016_j_biotechadv_2015_10_005
crossref_primary_10_1002_adom_201500658
crossref_primary_10_1007_s44174_024_00263_4
crossref_primary_10_1051_bioconf_202413300010
crossref_primary_10_1016_j_biotechadv_2015_11_004
crossref_primary_10_2196_24644
crossref_primary_10_1021_cr500116a
crossref_primary_10_1039_C5AN00054H
crossref_primary_10_1002_adhm_201400504
crossref_primary_10_1063_5_0057020
crossref_primary_10_1016_j_tibtech_2015_09_011
crossref_primary_10_1155_2018_8694357
crossref_primary_10_1039_C4AN02013H
crossref_primary_10_1039_C5AN00847F
crossref_primary_10_1016_j_aca_2014_08_006
crossref_primary_10_1002_pca_2617
crossref_primary_10_1177_1357633X16673275
crossref_primary_10_2196_jmir_5429
crossref_primary_10_1016_j_saa_2015_01_020
crossref_primary_10_1039_C4LC00142G
crossref_primary_10_1200_EDBK_173841
crossref_primary_10_1016_j_hlpt_2015_08_006
crossref_primary_10_2196_10187
crossref_primary_10_46388_ijass_2022_4_18
crossref_primary_10_1002_wnan_1455
crossref_primary_10_1021_ac504274q
crossref_primary_10_1177_1460458214567004
crossref_primary_10_1002_adma_201706910
crossref_primary_10_2196_jmir_7482
crossref_primary_10_1039_C5LC00577A
crossref_primary_10_2139_ssrn_4161641
crossref_primary_10_1021_acsnano_5b08176
crossref_primary_10_1039_C6CS00206D
crossref_primary_10_2174_1574892816666210728122304
crossref_primary_10_46388_ijass_2022_4_19
Cites_doi 10.1039/C2LC41152K
10.1371/journal.pone.0017150
10.1177/193229681200600525
10.2196/jmir.2600
10.1177/193229681300700130
10.1136/bmj.39071.441609.80
10.2196/jmir.2058
10.2196/jmir.2498
10.1136/bmj.f6009
10.1377/hlthaff.2009.0965
10.1177/193229681300700321
10.1039/c2lc40741h
10.1021/ac201587a
10.1111/j.1463-1318.2012.03088.x
10.1258/jtt.2011.101102
10.1016/j.surge.2010.07.014
10.1007/s10916-012-9903-6
10.1039/C2LC40864C
10.1007/s11999-011-1904-0
10.1186/1741-7015-10-46
10.1039/c1lc20479c
10.1136/qshc.2005.017467
10.1136/qshc.2008.028050
10.4258/hir.2011.17.2.131
10.1377/hlthaff.28.5.w849
10.1039/c3lc50431j
10.1039/c3lc50785h
10.1039/c003477k
10.1039/c2lc40235a
10.2196/jmir.2130
10.2196/jmir.1874
10.1038/nj7445-387a
10.1136/qshc.2004.010454
10.1258/jtt.2011.110205
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7SP
7TB
7U5
8FD
FR3
L7M
DOI 10.1039/c3lc51235e
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Electronics & Communications Abstracts
Mechanical & Transportation Engineering Abstracts
Solid State and Superconductivity Abstracts
Technology Research Database
Engineering Research Database
Advanced Technologies Database with Aerospace
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Solid State and Superconductivity Abstracts
Engineering Research Database
Technology Research Database
Mechanical & Transportation Engineering Abstracts
Advanced Technologies Database with Aerospace
Electronics & Communications Abstracts
DatabaseTitleList MEDLINE - Academic

MEDLINE
Solid State and Superconductivity Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Chemistry
Biology
EISSN 1473-0189
EndPage 84
ExternalDocumentID 24425070
10_1039_c3lc51235e
c3lc51235e
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0-7
0R~
0UZ
0VX
1TJ
29L
4.4
53G
5GY
705
70~
71~
7~J
AAEMU
AAIWI
AAJAE
AAMEH
AANOJ
AAWGC
AAXHV
AAXPP
AAYXX
ABASK
ABDVN
ABEMK
ABJNI
ABPDG
ABRYZ
ABXOH
ACGFS
ACHDF
ACIWK
ACLDK
ACRPL
ADMRA
ADNMO
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFFNX
AFLYV
AFOGI
AFRZK
AFVBQ
AGEGJ
AGKEF
AGQPQ
AGRSR
AHGCF
AHGXI
AKMSF
ALMA_UNASSIGNED_HOLDINGS
ALSGL
ANBJS
ANLMG
ANUXI
APEMP
ASKNT
AUDPV
BBWZM
BLAPV
BSQNT
C6K
CAG
CITATION
COF
CS3
DU5
EBS
ECGLT
EE0
EEHRC
EF-
EJD
F5P
FEDTE
GGIMP
GNO
H13
HVGLF
HZ~
H~N
IDY
IDZ
J3G
J3H
J3I
L-8
M4U
N9A
NDZJH
O9-
R56
R7B
RAOCF
RCLXC
RCNCU
RNS
ROL
RPMJG
RRA
RRC
RSCEA
SKA
SLH
VH6
-JG
AGSTE
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7SP
7TB
7U5
8FD
FR3
L7M
ID FETCH-LOGICAL-c405t-3d188817a49f884cfcc2908dafe328b6aba74133fdf3fa0e69ca3585b08de8463
ISSN 1473-0197
1473-0189
IngestDate Fri Jul 11 16:09:51 EDT 2025
Thu Jul 10 16:40:42 EDT 2025
Wed Feb 19 01:56:34 EST 2025
Tue Jul 01 00:52:35 EDT 2025
Thu Apr 24 23:00:16 EDT 2025
Thu May 19 04:22:37 EDT 2016
Thu May 30 17:31:47 EDT 2019
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c405t-3d188817a49f884cfcc2908dafe328b6aba74133fdf3fa0e69ca3585b08de8463
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24425070
PQID 1499132018
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1499132018
rsc_primary_c3lc51235e
pubmed_primary_24425070
crossref_citationtrail_10_1039_c3lc51235e
crossref_primary_10_1039_c3lc51235e
proquest_miscellaneous_1753505170
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-07
PublicationDateYYYYMMDD 2014-03-07
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-07
  day: 07
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Lab on a chip
PublicationTitleAlternate Lab Chip
PublicationYear 2014
References Cafazzo (c3lc51235e-(cit57)/*[position()=1]) 2012; 14
Barton (c3lc51235e-(cit11)/*[position()=1]) 2012; 10
Zhu (c3lc51235e-(cit17)/*[position()=1]) 2013; 13
Tseng (c3lc51235e-(cit12)/*[position()=1]) 2010; 10
Smith (c3lc51235e-(cit20)/*[position()=1]) 2011; 6
Shen (c3lc51235e-(cit18)/*[position()=1]) 2012; 12
Silva (c3lc51235e-(cit73)/*[position()=1]) 2013; 15
Franko (c3lc51235e-(cit66)/*[position()=1]) 2011; 469
Klonoff (c3lc51235e-(cit58)/*[position()=1]) 2013; 7
Vincent (c3lc51235e-(cit62)/*[position()=1]) 2004; 13
Coskun (c3lc51235e-(cit16)/*[position()=1]) 2013; 13
Oncescu (c3lc51235e-(cit19)/*[position()=1]) 2013; 13
Martínez-Pérez (c3lc51235e-(cit42)/*[position()=1]) 2013; 15
Choi (c3lc51235e-(cit70)/*[position()=1]) 2011; 17
Scheffler (c3lc51235e-(cit76)/*[position()=1]) 2009; 28
Kallander (c3lc51235e-(cit77)/*[position()=1]) 2013; 15
Chomutare (c3lc51235e-(cit60)/*[position()=1]) 2011; 13
Smith (c3lc51235e-(cit65)/*[position()=1]) 2010; 19
Visser (c3lc51235e-(cit48)/*[position()=1]) 2012; 18
Zhu (c3lc51235e-(cit13)/*[position()=1]) 2011; 83
Dance (c3lc51235e-(cit26)/*[position()=1]) 2013; 496
Rosser (c3lc51235e-(cit71)/*[position()=1]) 2011; 17
Runciman (c3lc51235e-(cit51)/*[position()=1]) 2006; 15 Suppl 1
Franko (c3lc51235e-(cit72)/*[position()=1]) 2012; 41
Arsand (c3lc51235e-(cit56)/*[position()=1]) 2012; 6
Sclafani (c3lc51235e-(cit68)/*[position()=1]) 2013; 37
Coskun (c3lc51235e-(cit15)/*[position()=1]) 2013; 13
Kahn (c3lc51235e-(cit1)/*[position()=1]) 2010; 29
Wang (c3lc51235e-(cit21)/*[position()=1]) 2011; 11
Dala-Ali (c3lc51235e-(cit67)/*[position()=1]) 2011; 9
El-Gayar (c3lc51235e-(cit61)/*[position()=1]) 2013; 7
O'Neill (c3lc51235e-(cit69)/*[position()=1]) 2012; 14
Vincent (c3lc51235e-(cit64)/*[position()=1]) 2007; 334
Mudanyali (c3lc51235e-(cit14)/*[position()=1]) 2012; 12
Kamerow (c3lc51235e-(cit46)/*[position()=1]) 2013; 347
de Jongh (c3lc51235e-(cit59)/*[position()=1]) 2012; 12
References_xml – issn: 2013
– doi: Borysiewicz
– issn: 2013
  publication-title: Keeping Up with Progress in Mobile Medical Apps
– publication-title: 510(k)
– start-page: 3
  issn: 2009
  issue: 2
  volume-title: Increase in remote patient monitoring predicts boon for home health care device
  publication-title: Med. Devices Bull.
  doi: Frost Sullivan
– issn: 2009
  publication-title: Vital Wave Consulting. mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World
– issn: 2012
  volume-title: Mobile Image Ratiometry: A New Method for Instantaneous Analysis of Rapid Test Strips
  publication-title: Nature Precedings
  doi: Cooper Callahan Callahan Burnett
– publication-title: Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff
– publication-title: uChek Universal: The medical lab in your phone
– publication-title: Draft Guidance for Industry and Food and Drug Administration Staff: Mobile Medical Applications
– publication-title: Case Study: Regulatory Pathways for Medical Devices: Choosing the Right One
– issn: 2013
  publication-title: National Medical Device Curriculum
  doi: Kalush
– publication-title: Mobile Phone Spirometry
– publication-title: Entrepeneurs in residence program
– publication-title: Medic Mobile
– doi: Chodor
– issn: 2012
  publication-title: ISO/IEC Guide 63:2012, Guide to the development and inclusion of safety aspects in International Standards for medical devices
– issn: 2006
  publication-title: M-Health: Emerging mobile health systems
  doi: Istepanian Laxminarayan Pattichis
– publication-title: 513(g)
– issn: 2008
  publication-title: Medical Error and Patient Safety: Human Factors in Medicine
  doi: Peters Peters
– publication-title: Case Study: Freedom from Unacceptable Risk: Making a Case for Safety Assurance and Risk Management
– issn: 2013
  publication-title: NHS Choices: Health Apps Library
– publication-title: Medical Devices Technology Innovation Partnership (MD-TIP) Workshop
– issn: 2004
  publication-title: Seven steps to patient safety, The full reference guide
– publication-title: Mobile Assay Inc.
– issn: 2013
  publication-title: Developing mobile apps as medical devices: Understanding U.S. government regulations, Developer Works, IBM
  doi: Gilmer
– issn: 2013
  publication-title: FDA's Regulation of Mobile Medical Apps Will Probably Confuse You, Device Talk, Medical Device and Diagnostic Industry
  doi: Wiltz
– issn: 2006
  publication-title: Federal Food, Drug, and Cosmetic Act (FD&C Act), 201(h)
– issn: 2013
  publication-title: Letter to Biosense Technologies Private Limited concerning the uChek Urine Analyzer
– publication-title: Premarket Approval (PMA)
– issn: 2012
  volume-title: Mobile Image Ratiometry for the Detection of Botrytis Cinerea (Gray Mold)
  publication-title: Nature Precedings
  doi: Cooper
– issn: 2006
– issn: 2004
  issue: vol. 1-6
  end-page: p 2212-2217
  publication-title: Probabilistic Safety Assessment and Management
  doi: Battles Kanki
– start-page: (3)
  issn: 2013
  issue: 7
  volume-title: How Helpful are Mobile Healthcare Apps?
  publication-title: AAOS Now
  doi: Franko
– publication-title: Holomic LLC
– issn: 2010
  publication-title: Patient Safety
  doi: Vincent
– volume: 13
  start-page: 636
  year: 2013
  ident: c3lc51235e-(cit15)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/C2LC41152K
– volume: 6
  start-page: e17150
  year: 2011
  ident: c3lc51235e-(cit20)/*[position()=1]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0017150
– volume: 12
  start-page: CD007459
  year: 2012
  ident: c3lc51235e-(cit59)/*[position()=1]
  publication-title: The Cochrane Database of Systematic Reviews
– volume: 6
  start-page: 1197
  year: 2012
  ident: c3lc51235e-(cit56)/*[position()=1]
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/193229681200600525
– volume: 15
  start-page: e120
  issue: 6
  year: 2013
  ident: c3lc51235e-(cit42)/*[position()=1]
  publication-title: J. Med. Internet Res.
  doi: 10.2196/jmir.2600
– volume: 7
  start-page: 247
  year: 2013
  ident: c3lc51235e-(cit61)/*[position()=1]
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/193229681300700130
– volume: 334
  start-page: 51
  year: 2007
  ident: c3lc51235e-(cit64)/*[position()=1]
  publication-title: Br. Med. J.
  doi: 10.1136/bmj.39071.441609.80
– volume: 14
  start-page: e70
  year: 2012
  ident: c3lc51235e-(cit57)/*[position()=1]
  publication-title: J. Med. Internet Res.
  doi: 10.2196/jmir.2058
– volume: 15
  start-page: e66
  year: 2013
  ident: c3lc51235e-(cit73)/*[position()=1]
  publication-title: J. Med. Internet Res.
  doi: 10.2196/jmir.2498
– volume: 347
  start-page: f6009
  year: 2013
  ident: c3lc51235e-(cit46)/*[position()=1]
  publication-title: Br. Med. J.
  doi: 10.1136/bmj.f6009
– volume: 29
  start-page: 252
  year: 2010
  ident: c3lc51235e-(cit1)/*[position()=1]
  publication-title: Health Aff.
  doi: 10.1377/hlthaff.2009.0965
– volume: 7
  start-page: 749
  year: 2013
  ident: c3lc51235e-(cit58)/*[position()=1]
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/193229681300700321
– volume: 12
  start-page: 4240
  year: 2012
  ident: c3lc51235e-(cit18)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc40741h
– volume: 83
  start-page: 6641
  year: 2011
  ident: c3lc51235e-(cit13)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac201587a
– volume: 14
  start-page: e530
  year: 2012
  ident: c3lc51235e-(cit69)/*[position()=1]
  publication-title: Colorectal Disease : The Official Journal of the Association of Coloproctology of Great Britain and Ireland
  doi: 10.1111/j.1463-1318.2012.03088.x
– volume: 17
  start-page: 308
  year: 2011
  ident: c3lc51235e-(cit71)/*[position()=1]
  publication-title: J. Telemed. Telecare
  doi: 10.1258/jtt.2011.101102
– volume: 9
  start-page: 44
  year: 2011
  ident: c3lc51235e-(cit67)/*[position()=1]
  publication-title: The Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
  doi: 10.1016/j.surge.2010.07.014
– volume: 37
  start-page: 9903
  issue: 1
  year: 2013
  ident: c3lc51235e-(cit68)/*[position()=1]
  publication-title: J. Med. Syst.
  doi: 10.1007/s10916-012-9903-6
– volume: 13
  start-page: 51
  year: 2013
  ident: c3lc51235e-(cit17)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/C2LC40864C
– volume: 469
  start-page: 2042
  year: 2011
  ident: c3lc51235e-(cit66)/*[position()=1]
  publication-title: Clin. Orthop. Relat. Res.
  doi: 10.1007/s11999-011-1904-0
– volume: 10
  start-page: 46
  year: 2012
  ident: c3lc51235e-(cit11)/*[position()=1]
  publication-title: BMC Med.
  doi: 10.1186/1741-7015-10-46
– volume: 41
  start-page: 526
  year: 2012
  ident: c3lc51235e-(cit72)/*[position()=1]
  publication-title: Am. J. Orthop.
– volume: 11
  start-page: 3411
  year: 2011
  ident: c3lc51235e-(cit21)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c1lc20479c
– volume: 15 Suppl 1
  start-page: i82
  year: 2006
  ident: c3lc51235e-(cit51)/*[position()=1]
  publication-title: Quality & Safety in Health Care
  doi: 10.1136/qshc.2005.017467
– volume: 19
  start-page: 69
  year: 2010
  ident: c3lc51235e-(cit65)/*[position()=1]
  publication-title: Qual. Saf. Health Care
  doi: 10.1136/qshc.2008.028050
– volume: 17
  start-page: 131
  year: 2011
  ident: c3lc51235e-(cit70)/*[position()=1]
  publication-title: Healthcare Inf. Res.
  doi: 10.4258/hir.2011.17.2.131
– volume: 28
  start-page: w849
  year: 2009
  ident: c3lc51235e-(cit76)/*[position()=1]
  publication-title: Health Aff.
  doi: 10.1377/hlthaff.28.5.w849
– volume: 13
  start-page: 3232
  year: 2013
  ident: c3lc51235e-(cit19)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c3lc50431j
– volume: 13
  start-page: 4231
  year: 2013
  ident: c3lc51235e-(cit16)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c3lc50785h
– volume: 10
  start-page: 1787
  year: 2010
  ident: c3lc51235e-(cit12)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c003477k
– volume: 12
  start-page: 2678
  year: 2012
  ident: c3lc51235e-(cit14)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc40235a
– volume: 15
  start-page: e17
  year: 2013
  ident: c3lc51235e-(cit77)/*[position()=1]
  publication-title: J. Med. Internet Res.
  doi: 10.2196/jmir.2130
– volume: 13
  start-page: e65
  year: 2011
  ident: c3lc51235e-(cit60)/*[position()=1]
  publication-title: J. Med. Internet Res.
  doi: 10.2196/jmir.1874
– volume: 496
  start-page: 387
  year: 2013
  ident: c3lc51235e-(cit26)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nj7445-387a
– volume: 13
  start-page: 242
  year: 2004
  ident: c3lc51235e-(cit62)/*[position()=1]
  publication-title: Quality and Safety in Health Care
  doi: 10.1136/qshc.2004.010454
– volume: 18
  start-page: 124
  year: 2012
  ident: c3lc51235e-(cit48)/*[position()=1]
  publication-title: J. Telemed. Telecare
  doi: 10.1258/jtt.2011.110205
SSID ssj0015468
Score 2.381469
SecondaryResourceType review_article
Snippet The rapidly expanding number of mobile medical applications have the potential to transform the patient-healthcare provider relationship by improving the...
SourceID proquest
pubmed
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 833
SubjectTerms Applications programs
Assessments
Control
Government Regulation
Guidelines as Topic
Humans
Internet
Markets
Medical
Medical Records Systems, Computerized - standards
Mobile Applications - economics
Mobile Applications - standards
Obstacles
Patients
Patients - psychology
Physicians - psychology
Risk
Risk Assessment
Software
Title The regulation of mobile medical applications
URI https://www.ncbi.nlm.nih.gov/pubmed/24425070
https://www.proquest.com/docview/1499132018
https://www.proquest.com/docview/1753505170
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAUL
  databaseName: Royal Society of Chemistry Gold Collection 2023
  customDbUrl: https://pubs.rsc.org
  eissn: 1473-0189
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0015468
  issn: 1473-0197
  databaseCode: AETIL
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.rsc.org/journals-books-databases/librarians-information/products-prices/#undefined
  providerName: Royal Society of Chemistry
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwFLagIwQcEBSG6bAoCC4oSnBqp3GOo6qoQIdTB80t8hZpRNpUXQ7TX89z7CzQCg1cosixs_g9O9_bEfqAucZccR7IFKuA5kkES4qLYCg4iM-RSpQ2-o7L76PpFf16HV-3rrxVdMlWhHJ_NK7kf6gKbUBXEyX7D5RtbgoNcA70hSNQGI53pvHaFpN3uG9RCljm1mJusgB0zNNdGDrjwlgJuInlXrVqU1OY2aYUKG78b3rBW6fBKtuA3gfTHcB1Zc01oT8L6w6K--P1bu__4BtpIiGLwvrvOT112WhybhYb_dOFH16G_jj0JwvngOuUDxGtvK-Szn5JE-OOZV1sQ91ts5WBmk2Wdpgp7uyYzObBONjJMTGJUCUpZGzCeXX7v6pt9H_8xhrnwsqsTtKsHXsfnQxh08c9dHIxmX-ZNWammNpYyfor6vy1JP3Ujv4dsRyIIQBK1nWxmAqUzJ-iJ06a8C4sazxD9_Syjx7Y-qK3ffRwXJfz66PHncyTz1EArOO1rOOVuWdZx3Os43VZ5wW6-jyZj6eBq5wRSADg24CoiDEWJZymOWNU5lIOU8wUzzUZMjHiggOSJCRXOck51qNUcgKCo4A-GhApOUW9ZbnUZ8ijCicaC6xgRVPAejA4TWUC88KIgrsO0Md6djLp0sqb6iZFdkiHAXrf9F3ZZCpHe72rJzmDOTIcy5e63G1ATAVphgAfsr_0Afk7Nonn8AC9tBRqngVQFhC_uXIKJGuau48-P34hW6n8_E5v_wo9ahfKa9Tbrnf6DeDWrXjruO8XxtmWaw
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+regulation+of+mobile+medical+applications&rft.jtitle=Lab+on+a+chip&rft.au=Yetisen%2C+Ali+Kemal&rft.au=Martinez-Hurtado%2C+J.+L.&rft.au=da+Cruz+Vasconcellos%2C+Fernando&rft.au=Simsekler%2C+M.+C.+Emre&rft.date=2014-03-07&rft.issn=1473-0197&rft.eissn=1473-0189&rft.volume=14&rft.issue=5&rft.spage=833&rft_id=info:doi/10.1039%2Fc3lc51235e&rft.externalDBID=n%2Fa&rft.externalDocID=10_1039_c3lc51235e
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-0197&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-0197&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-0197&client=summon